Literature DB >> 16460673

The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells.

Fatima Khwaja1, Arshia Tabassum, Jeff Allen, Daniel Djakiew.   

Abstract

The p75 neurotrophin receptor (p75(NTR)) is a death receptor which belongs to the tumor necrosis factor receptor super-family of membrane proteins. This study shows that p75(NTR) retarded cell cycle progression by induced accumulation of cells in G0/G1 and a reduction in the S phase of the cell cycle. The rescue of tumor cells from cell cycle progression by a death domain deleted (DeltaDD) dominant-negative antagonist of p75(NTR) showed that the death domain transduced anti-proliferative activity in a ligand-independent manner. Conversely, addition of NGF ligand rescued retardation of cell cycle progression with commensurate changes in components of the cyclin/cdk holoenzyme complex. In the absence of ligand, p75(NTR)-dependent cell cycle arrest facilitated an increase in apoptotic nuclear fragmentation of the prostate cancer cells. Apoptosis of p75(NTR) expressing cells occurred via the intrinsic mitochondrial pathway leading to a sequential caspase-9 and -7 cascade. Since the death domain deleted dominant-negative antagonist of p75(NTR) rescued intrinsic caspase associated apoptosis in PC-3 cells, this shows p75(NTR) was integral to ligand independent induction of apoptosis. Moreover, the ability of ligand to ameliorate the p75(NTR)-dependent intrinsic apoptotic cascade indicates that NGF functioned as a survival factor for p75(NTR) expressing prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460673     DOI: 10.1016/j.bbrc.2006.01.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

Review 1.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

Review 2.  A Bex-cycle built for two.

Authors:  Bruce D Carter
Journal:  EMBO Rep       Date:  2006-04       Impact factor: 8.807

3.  NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway.

Authors:  Shehla Wynne; Daniel Djakiew
Journal:  Mol Cancer Res       Date:  2010-11-19       Impact factor: 5.852

4.  The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.

Authors:  Angèle Nalbandian; Daniel Djakiew
Journal:  Clin Exp Metastasis       Date:  2006-08-16       Impact factor: 5.150

5.  Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.

Authors:  Osama A Elkashty; Ghada Abu Elghanam; Xinyun Su; Younan Liu; Peter J Chauvin; Simon D Tran
Journal:  Carcinogenesis       Date:  2020-06-17       Impact factor: 4.944

6.  Biochanin A reduces drug-induced p75NTR expression and enhances cell survival: a new in vitro assay for screening inhibitors of p75NTR expression.

Authors:  Lara H El Touny; Fraser Henderson; Daniel Djakiew
Journal:  Rejuvenation Res       Date:  2010-09-06       Impact factor: 4.663

7.  Nerve growth factor attenuates proliferation of astrocytes via the p75 neurotrophin receptor.

Authors:  Andrea B Cragnolini; Yangyang Huang; Pradeepa Gokina; Wilma J Friedman
Journal:  Glia       Date:  2009-10       Impact factor: 7.452

8.  p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells.

Authors:  Peter A Forsyth; Niveditha Krishna; Samuel Lawn; J Gerardo Valadez; Xiaotao Qu; David A Fenstermacher; Michelle Fournier; Lisa Potthast; Prakash Chinnaiyan; Geoffrey T Gibney; Michele Zeinieh; Philip A Barker; Bruce D Carter; Michael K Cooper; Rajappa S Kenchappa
Journal:  J Biol Chem       Date:  2014-02-11       Impact factor: 5.157

9.  Carprofen induction of p75NTR-dependent apoptosis via the p38 mitogen-activated protein kinase pathway in prostate cancer cells.

Authors:  Fatima S Khwaja; Emily J Quann; Nagarajan Pattabiraman; Shehla Wynne; Daniel Djakiew
Journal:  Mol Cancer Ther       Date:  2008-10-30       Impact factor: 6.261

Review 10.  Neurotrophin signaling in cancer stem cells.

Authors:  Valérie Chopin; Chann Lagadec; Robert-Alain Toillon; Xuefen Le Bourhis
Journal:  Cell Mol Life Sci       Date:  2016-02-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.